Annual Cash & Cash Equivalents:
$2.05B-$289.00M(-12.38%)Summary
- As of today, VEON annual cash & cash equivalents is $2.05 billion, with the most recent change of -$289.00 million (-12.38%) on December 31, 2024.
- During the last 3 years, VEON annual cash & cash equivalents has fallen by -$292.00 million (-12.49%).
- VEON annual cash & cash equivalents is now -67.74% below its all-time high of $6.34 billion, reached on December 31, 2014.
Performance
VEON Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$1.66B-$123.48M(-6.91%)Summary
- As of today, VEON quarterly cash & cash equivalents is $1.66 billion, with the most recent change of -$123.48 million (-6.91%) on September 30, 2025.
- Over the past year, VEON quarterly cash & cash equivalents has increased by +$37.57 million (+2.31%).
- VEON quarterly cash & cash equivalents is now -74.41% below its all-time high of $6.50 billion, reached on March 31, 2015.
Performance
VEON Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
VEON Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -12.4% | +2.3% |
| 3Y3 Years | -12.5% | -51.3% |
| 5Y5 Years | +63.7% | +53.8% |
VEON Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -36.6% | at low | -51.3% | +26.5% |
| 5Y | 5-Year | -36.6% | +63.7% | -51.3% | +53.8% |
| All-Time | All-Time | -67.7% | +131.2% | -74.4% | +74.1% |
VEON Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $1.66B(-6.9%) |
| Jun 2025 | - | $1.79B(-16.2%) |
| Mar 2025 | - | $2.13B(+4.2%) |
| Dec 2024 | $2.05B(-12.4%) | $2.05B(+25.9%) |
| Sep 2024 | - | $1.63B(+13.5%) |
| Jun 2024 | - | $1.43B(+9.0%) |
| Mar 2024 | - | $1.31B(-43.7%) |
| Dec 2023 | $2.33B(-27.6%) | $2.34B(-3.0%) |
| Sep 2023 | - | $2.41B(-7.1%) |
| Jun 2023 | - | $2.59B(-18.6%) |
| Mar 2023 | - | $3.18B(+2.5%) |
| Dec 2022 | $3.23B(+38.0%) | $3.11B(-9.0%) |
| Sep 2022 | - | $3.41B(+39.2%) |
| Jun 2022 | - | $2.45B(+18.6%) |
| Mar 2022 | - | $2.07B(-8.2%) |
| Dec 2021 | $2.34B(+40.1%) | $2.25B(+50.3%) |
| Sep 2021 | - | $1.50B(+25.7%) |
| Jun 2021 | - | $1.19B(-0.1%) |
| Mar 2021 | - | $1.19B(-28.5%) |
| Dec 2020 | $1.67B(+33.5%) | $1.67B(+54.4%) |
| Sep 2020 | - | $1.08B(-7.2%) |
| Jun 2020 | - | $1.17B(-21.6%) |
| Mar 2020 | - | $1.49B(+18.9%) |
| Dec 2019 | $1.25B(-30.8%) | $1.25B(-9.9%) |
| Sep 2019 | - | $1.39B(-33.7%) |
| Jun 2019 | - | $2.09B(+65.4%) |
| Mar 2019 | - | $1.26B(-30.0%) |
| Dec 2018 | $1.81B(+37.5%) | $1.81B(-46.4%) |
| Sep 2018 | - | $3.37B(+150.9%) |
| Jun 2018 | - | $1.34B(-3.6%) |
| Mar 2018 | - | $1.39B(+6.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $1.31B(-55.3%) | $1.31B(-48.8%) |
| Sep 2017 | - | $2.56B(-10.4%) |
| Jun 2017 | - | $2.86B(+31.7%) |
| Mar 2017 | - | $2.17B(-26.2%) |
| Dec 2016 | $2.94B(-18.6%) | $2.94B(-20.2%) |
| Sep 2016 | - | $3.68B(+1.4%) |
| Jun 2016 | - | $3.63B(+24.1%) |
| Mar 2016 | - | $2.93B(-19.0%) |
| Dec 2015 | $3.61B(-43.0%) | $3.61B(-8.0%) |
| Sep 2015 | - | $3.93B(-6.9%) |
| Jun 2015 | - | $4.22B(-35.0%) |
| Mar 2015 | - | $6.50B(+2.4%) |
| Dec 2014 | $6.34B(+42.4%) | $6.34B(+8.4%) |
| Sep 2014 | - | $5.85B(+0.8%) |
| Jun 2014 | - | $5.80B(+16.1%) |
| Mar 2014 | - | $5.00B(+12.3%) |
| Dec 2013 | $4.45B(-10.0%) | $4.45B(-8.9%) |
| Sep 2013 | - | $4.89B(+7.5%) |
| Jun 2013 | - | $4.55B(+40.4%) |
| Dec 2012 | $4.95B(+112.9%) | - |
| Sep 2012 | - | $3.24B(+12.4%) |
| Jun 2012 | - | $2.88B(+24.0%) |
| Dec 2011 | $2.33B(+162.7%) | $2.32B(-5.1%) |
| Mar 2011 | - | $2.45B(+156.6%) |
| Dec 2010 | $885.13M(-38.8%) | $954.92M(-61.3%) |
| Sep 2010 | - | $2.47B(+4.8%) |
| Jun 2010 | - | $2.35B(+53.8%) |
| Mar 2010 | - | $1.53B(+5.7%) |
| Dec 2009 | $1.45B(+58.2%) | $1.45B |
| Dec 2008 | $914.68M(-8.9%) | - |
| Dec 2007 | $1.00B | - |
FAQ
- What is VEON Ltd. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for VEON Ltd.?
- What is VEON Ltd. annual cash & cash equivalents year-on-year change?
- What is VEON Ltd. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for VEON Ltd.?
- What is VEON Ltd. quarterly cash & cash equivalents year-on-year change?
What is VEON Ltd. annual cash & cash equivalents?
The current annual cash & cash equivalents of VEON is $2.05B
What is the all-time high annual cash & cash equivalents for VEON Ltd.?
VEON Ltd. all-time high annual cash & cash equivalents is $6.34B
What is VEON Ltd. annual cash & cash equivalents year-on-year change?
Over the past year, VEON annual cash & cash equivalents has changed by -$289.00M (-12.38%)
What is VEON Ltd. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of VEON is $1.66B
What is the all-time high quarterly cash & cash equivalents for VEON Ltd.?
VEON Ltd. all-time high quarterly cash & cash equivalents is $6.50B
What is VEON Ltd. quarterly cash & cash equivalents year-on-year change?
Over the past year, VEON quarterly cash & cash equivalents has changed by +$37.57M (+2.31%)